Black Diamond Therapeutics, Inc. (BDTX) stock
BDTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.44−0.09 (-5.88%)
Close on Nov 17, 2026Market cap $82.73MP/E –Yield –
Black Diamond Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Black Diamond Therapeutics's market cap was $92.49M on Nov 11, 2026, against $217.52M a year earlier. Over the last 5 years it ranged from $52.10M to $344.09M, with a median of $124.69M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $92.49M | -33.2% |
| 2025 | Dec 31, 2025 | $138.37M | +14.4% |
| 2024 | Dec 31, 2024 | $120.96M | -16.6% |
| 2023 | Dec 29, 2023 | $145.09M | +121.7% |
| 2022 | Dec 30, 2022 | $65.46M | -66.1% |
| 2021 | Dec 31, 2021 | $193.10M | -83.2% |
| 2020 | Dec 31, 2020 | $1.15B | – |
See a number that looks wrong?